$1.570
-0.153 (-9.77%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACRV por análisis de gráficos similares
Alphio's ACRV stock price prediction model matches the current Acrivon Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.57 (+0.24%). The 1-week path is $1.60 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Acrivon Therapeutics, Inc.?
Acrivon Therapeutics Inc is currently not a strong buy due to its low price and negative earnings, but it shows potential for recovery. The current price is $1.61, significantly below the 52-week high of $3.56, indicating a 14.8% position within its 52-week range. However, the RSI is at 27.156, suggesting the stock is oversold, which could indicate a potential rebound. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the company has reported consistent losses, with a net income of -$19,042,000 in Q1 2026. The main risk is the ongoing negative earnings trend, as indicated by the EPS of -0.49 for Q1 2026, which may deter investors in the short term.
ACRV cerró en $1.57 el Thursday, tras bajar -9.77%
Acrivon Therapeutics, Inc. (ACRV) last closed at $1.5700001, losing -9.77%. These facts feed the 1-day and 1-week ACRV price prediction above.
Factores de la previsión
Los factores de la previsión de Acrivon Therapeutics, Inc. (ACRV) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACRV, ordenadas por similitud.
Análisis de estacionalidad de ACRV
Historically the probability of a positive November return for ACRV is 45.45%. December offers the highest probability of a positive month at 48.84%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACRV
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.48 | $1.55 | $1.73 | -1.42% |
| Dec 2026 | $1.21 | $1.27 | $1.53 | -19.31% |
En 2026, se proyecta que Acrivon Therapeutics, Inc. (ACRV) oscile entre $1.21 y $1.73.
Previsión mensual de Acrivon Therapeutics, Inc. para 2026
En Nov de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.55, con un mínimo de $1.48 y un máximo de $1.73.
En Dec de 2026, se proyecta que Acrivon Therapeutics, Inc. promedie $1.27, con un mínimo de $1.21 y un máximo de $1.53.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.